CHRISTOPHER KIKER: Open Payments
NPI 1679908057 · TOCCOA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,631 in 109 payments from 25 companies in 2025. Trend: 2023 $1,674 · 2024 $1,545 · 2025 $1,631
Food & beverage: $1,631
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $163 |
| Novo Nordisk Inc | 9 | $158 |
| ABBVIE INC. | 16 | $157 |
| PFIZER INC. | 10 | $155 |
| GlaxoSmithKline, LLC. | 9 | $141 |
| Otsuka America Pharmaceutical, Inc. | 6 | $139 |
| Amgen Inc. | 13 | $137 |
| Lilly USA, LLC | 9 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $66 |
| Axsome Therapeutics, Inc. | 3 | $46 |
Products named: REXULTI, TRELEGY ELLIPTA, ELIQUIS, OTEZLA, MOUNJARO, JARDIANCE, VRAYLAR, Rybelsus.
Industry payments across GA — which companies pay providers there.
